ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPECIALS

Special Spring 2024

Bioprocessing & Precision Fermentation

The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These … more ➔

Special Winter 2023

Euro BioFairs Compass

Guide to Life Sciences Events in the first half year of 2024 more ➔

ADVERTISEMENT

Special Autumn 2023

CROs & CDMOs

Since 2006, the share of biomanufacturers producing everything in-house have declined from 57.6% to 34.9% in 2022. According to biopharmaceutical companies, the percentage is to decrease to 20% by 2026, … more ➔

Special Summer 2023

Euro BioFairs Compass

2nd half year 2023 more ➔

Page 2 of 212

LATEST NEWS

Novo logoAdobe stock photos - https://european-biotechnology.com/latest-news/roche-moves-obesity-asset-ct-388-into-phase-iii/

Novo and Pfizer in Metsera takeover battle

Opening speech of Marc Rutte at the first ever NATO Biotech ConferenceNATO

NATO elevates biotech to defence priority

GSK's incoming CEO Luke MielsGSK

GSK licences siRNA COPD drug in US$745m biobucks de...

ADVERTISEMENT

MAGAZINE

1 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

2 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

3 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

4 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

SPONSORED PUBLICATION

1 / 2
Image 960x540
Gene Therapy

Innovative Approaches to Gene Therapy

Watch this expert-led session to explore the latest trends and insights in gene therapy, including how to model immunosuppressive regimens, key study-design considerations, and the importance of age … more ➔

2 / 2
25Q3_Digitizing-Mfg-for-Annex-11-and-MHRA-Rediness_Banners_960x540
Whitepaper Digital Manufacturing

Tackling 5 Key Challenges in Annex 11 and MHRA Readiness

Download the guide to explore how forward-thinking organisations are leveraging digital transformation in manufacturing to overcome regulatory challenges, enhance compliance, and gain operational … more ➔

newsletter_link
© BIOCOM Interrelations GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top